Search for: "Momenta Pharma, Inc. v. Teva Pharma. USA, Inc."
Results 1 - 10
of 10
Sorted by Relevance
|
Sort by Date
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to… [read post]
14 Apr 2014, 3:51 pm
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
28 Sep 2016, 8:39 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
16 Jan 2017, 5:44 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to… [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
